S100A16 Gene

HGNC Family EF-hand domain containing, S100 calcium binding proteins (S100)
Name S100 calcium binding protein A16
Description Enables calcium ion binding activity and protein homodimerization activity. Predicted to act upstream of or within response to calcium ion. Located in several cellular components, including cytosol; extracellular space; and nucleolus. [provided by Alliance of Genome Resources, Mar 2025]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nS100A16 is a member of the S100 calcium‐binding protein family with distinctive structural features, including a minimal conformational change upon calcium binding that is attributed to its unique EF‐hand configuration and specific hydrophobic interactions."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn several human tumors, including breast, oral squamous cell, prostate, colorectal, and pancreatic cancers, aberrant expression of S100A16 has been observed. In breast cancer, S100A16 (alongside its family member S100A14) may influence tumor progression, although its precise function remains to be fully elucidated."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " By contrast, in oral squamous cell carcinoma, altered S100A16 levels have been linked to suppressive tumor phenotypes"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": ", while in prostate cancer, its overexpression promotes cellular invasion, migration, and proliferation by modulating the AKT and ERK pathways as well as downregulating cell cycle inhibitors."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": " Moreover, studies in colorectal cancer have indicated that downregulation of S100A16 may relieve its inhibitory effects on epithelial-to-mesenchymal transition (EMT), further impacting cellular behavior."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": " In pancreatic ductal adenocarcinoma, two independent studies have demonstrated that S100A16 overexpression drives proliferation, invasion, and metastasis via activation of the AKT/ERK1/2 cascade in an FGF19-dependent manner."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to solid tumors, dysregulation of S100A16 features in hematologic malignancies and other aggressive cancer subtypes. In lung adenocarcinoma, for example, S100A16 has been associated with adverse clinical outcomes through its interaction with RNA helicases such as MOV10 to stabilize ITGA3 mRNA and thus modulate extracellular matrix–receptor signaling."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "11"}]}, {"type": "t", "text": " Meanwhile, in small cell lung cancer (SCLC) brain metastasis, the upregulation of S100A16—mediated in part by exosomes from brain microvascular endothelial cells—confers a survival advantage under stress by preserving mitochondrial membrane potential."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "13"}]}, {"type": "t", "text": " In B-cell acute lymphoblastic leukemia, altered S100A16 transcript levels have been shown to influence relapse and overall survival, with functional studies implicating stress survival pathways such as PI3K/AKT and ERK1/2."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "14"}]}, {"type": "t", "text": " Similarly, in cervical cancer cells, overexpression of S100A16 enhances proliferative, migratory, and angiogenic capabilities mediated by PI3K/AKT signaling"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "15"}]}, {"type": "t", "text": ", and in glioma, S100A16 promotes tumor progression by repressing Hippo signaling via CUL4A-mediated degradation of LATS1."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "16"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its roles in oncogenesis, S100A16 modulates several non–tumor cell functions. In hepatocytes, overexpression of S100A16 promotes lipid synthesis by upregulating the HSPA5/IRE1α–XBP1 signaling pathway, which in turn increases lipogenic gene expression."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "17"}]}, {"type": "t", "text": " In the context of renal pathology, increased S100A16 expression has been associated with tubulointerstitial fibrosis; mechanistic studies indicate that S100A16 interacts with GRP78, thereby modulating endoplasmic reticulum stress responses."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "18"}]}, {"type": "t", "text": " Additionally, evidence from renal cell cancer research further supports an association between S100A16 expression and kidney tumor biology."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "20"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nS100A16 also plays roles in cellular differentiation. In studies using placenta-derived multipotent stem cells, co-silencing of S100A16 together with HSP27 has been shown to promote differentiation into functional astrocytes, highlighting its involvement in neural cell fate decisions."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "21"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nFinally, emerging data underscore the broader clinical relevance of S100A16 in digestive system disorders and liver cancer, as well as in pancreatic cancer drug resistance mediated by noncoding RNA networks. A review of its expression in digestive system diseases accentuates its potential as both a prognostic marker and a therapeutic target"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "22"}]}, {"type": "t", "text": ", while studies in pancreatic cancer have revealed that a circRNA/miR-145/S100A16 axis contributes to gemcitabine resistance."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "24"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Elena Babini, Ivano Bertini, Valentina Borsi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structural characterization of human S100A16, a low-affinity calcium binder."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Inorg Chem (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00775-010-0721-3"}], "href": "https://doi.org/10.1007/s00775-010-0721-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21046186"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21046186"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Suyog Basnet, Evan Michael Vallenari, Urusha Maharjan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "An Update on S100A16 in Human Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomolecules (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/biom13071070"}], "href": "https://doi.org/10.3390/biom13071070"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37509106"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37509106"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Wenbin Zhou, Hong Pan, Tiansong Xia, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Up-regulation of S100A16 expression promotes epithelial-mesenchymal transition via Notch1 pathway in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biomed Sci (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12929-014-0097-8"}], "href": "https://doi.org/10.1186/s12929-014-0097-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25287362"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25287362"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Mizuko Tanaka, Naoki Ichikawa-Tomikawa, Namiko Shishito, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Co-expression of S100A14 and S100A16 correlates with a poor prognosis in human breast cancer and promotes cancer cell invasion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cancer (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12885-015-1059-6"}], "href": "https://doi.org/10.1186/s12885-015-1059-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25884418"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25884418"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Dipak Sapkota, Ove Bruland, Himalaya Parajuli, et al. "}, {"type": "b", "children": [{"type": "t", "text": "S100A16 promotes differentiation and contributes to a less aggressive tumor phenotype in oral squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cancer (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12885-015-1622-1"}], "href": "https://doi.org/10.1186/s12885-015-1622-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26353754"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26353754"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Weidong Zhu, Yi Xue, Chao Liang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "S100A16 promotes cell proliferation and metastasis via AKT and ERK cell signaling pathways in human prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13277-016-5096-9"}], "href": "https://doi.org/10.1007/s13277-016-5096-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27240591"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27240591"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Xu Sun, Teng Wang, Chun Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "S100A16 is a prognostic marker for colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Surg Oncol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jso.24822"}], "href": "https://doi.org/10.1002/jso.24822"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28876468"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28876468"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Shiyu Ou, Yan Liao, Jie Shi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "S100A16 suppresses the proliferation, migration and invasion of colorectal cancer cells in part via the JNK/p38 MAPK pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med Rep (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/mmr.2020.11803"}], "href": "https://doi.org/10.3892/mmr.2020.11803"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33355370"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33355370"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Ting Li, Tianyi Ren, Chumei Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "S100A16 induces epithelial-mesenchymal transition in human PDAC cells and is a new therapeutic target for pancreatic cancer treatment that synergizes with gemcitabine."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Pharmacol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bcp.2020.114396"}], "href": "https://doi.org/10.1016/j.bcp.2020.114396"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33359364"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33359364"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Dan Fang, Chengfei Zhang, Ping Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "S100A16 promotes metastasis and progression of pancreatic cancer through FGF19-mediated AKT and ERK1/2 pathways."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Biol Toxicol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10565-020-09574-w"}], "href": "https://doi.org/10.1007/s10565-020-09574-w"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33389337"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33389337"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Makoto Kobayashi, Ryo Nagashio, Keita Saito, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Prognostic significance of S100A16 subcellular localization in lung adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Pathol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.humpath.2018.01.001"}], "href": "https://doi.org/10.1016/j.humpath.2018.01.001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29320753"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29320753"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Lianren Yang, Ajuan Shen, Rujun Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "S100A16 stabilizes the ITGA3‑mediated ECM‑receptor interaction pathway to drive the malignant properties of lung adenocarcinoma cells via binding MOV10."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med Rep (2025)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/mmr.2024.13376"}], "href": "https://doi.org/10.3892/mmr.2024.13376"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "39450567"}], "href": "https://pubmed.ncbi.nlm.nih.gov/39450567"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Zhi-Hua Xu, Zi-Wei Miao, Qian-Zhu Jiang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Brain microvascular endothelial cell exosome-mediated S100A16 up-regulation confers small-cell lung cancer cell survival in brain."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FASEB J (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1096/fj.201800428R"}], "href": "https://doi.org/10.1096/fj.201800428R"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30183374"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30183374"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Jing Zhang, Wen-Yi Lu, Jia-Min Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "S100A16 suppresses the growth and survival of leukaemia cells and correlates with relapse and relapse free survival in adults with Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Haematol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/bjh.15878"}], "href": "https://doi.org/10.1111/bjh.15878"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30916375"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30916375"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Haibin Zhang, Yongxiu Yang, Xueyao Ma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "S100A16 Regulates HeLa Cell through the Phosphatidylinositol 3 Kinase (PI3K)/AKT Signaling Pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Med Sci Monit (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.12659/MSM.919757"}], "href": "https://doi.org/10.12659/MSM.919757"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31894756"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31894756"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Yifang Hu, Rihua Zhang, Shan Lu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "S100 Calcium Binding Protein A16 Promotes Cell Proliferation by triggering LATS1 ubiquitin degradation mediated by CUL4A ligase to inhibit Hippo pathway in Glioma development."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Biol Sci (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7150/ijbs.79924"}], "href": "https://doi.org/10.7150/ijbs.79924"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37151881"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37151881"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Jing-Bao Kan, Ge-Qian Shen, Jie Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "[S100 calcium binding protein A16 promotes fat synthesis through endoplasmic reticulum stress in HepG2 cells]."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sheng Li Xue Bao (2019)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31008487"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31008487"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Hui Sun, Anran Zhao, Min Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Interaction of calcium binding protein S100A16 with myosin-9 promotes cytoskeleton reorganization in renal tubulointerstitial fibrosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-020-2337-z"}], "href": "https://doi.org/10.1038/s41419-020-2337-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32094322"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32094322"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Runbing Jin, Anran Zhao, Shuying Han, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The interaction of S100A16 and GRP78 actives endoplasmic reticulum stress-mediated through the IRE1α/XBP1 pathway in renal tubulointerstitial fibrosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-021-04249-8"}], "href": "https://doi.org/10.1038/s41419-021-04249-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34645789"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34645789"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Ning Wang, Rongjiang Wang, Jianer Tang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Calbindin S100A16 Promotes Renal Cell Carcinoma Progression and Angiogenesis via the VEGF/VEGFR2 Signaling Pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Contrast Media Mol Imaging (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2022/5602011"}], "href": "https://doi.org/10.1155/2022/5602011"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36176934"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36176934"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Yu-Che Cheng, Chi-Jung Huang, Wei-Chi Ku, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Downregulated Calcium-Binding Protein S100A16 and HSP27 in Placenta-Derived Multipotent Cells Induce Functional Astrocyte Differentiation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Stem Cell Rev Rep (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12015-021-10319-3"}], "href": "https://doi.org/10.1007/s12015-021-10319-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35061207"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35061207"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Binbin Li, Wanqing Zhu, Di Shi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "New progress with calcium-binding protein S100A16 in digestive system disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Expert Rev Gastroenterol Hepatol (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/17474124.2023.2174968"}], "href": "https://doi.org/10.1080/17474124.2023.2174968"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36718596"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36718596"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Dashuai Yang, Fangrui Zhao, Yu Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "S100A16 is a potential target for reshaping the tumor microenvironment in the hypoxic context of liver cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int Immunopharmacol (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.intimp.2024.112076"}], "href": "https://doi.org/10.1016/j.intimp.2024.112076"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38733818"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38733818"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Shuo Yu, Min Wang, Hang Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Resistance to gemcitabine is mediated by the circ_0036627/miR-145/S100A16 axis in pancreatic cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Mol Med (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jcmm.18444"}], "href": "https://doi.org/10.1111/jcmm.18444"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38924205"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38924205"}]}]}]}
Synonyms DT1P1A7, S100F, AAG13
Proteins S10AG_HUMAN
NCBI Gene ID 140576
API
Download Associations
Predicted Functions View S100A16's ARCHS4 Predicted Functions.
Co-expressed Genes View S100A16's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View S100A16's ARCHS4 Predicted Functions.

Functional Associations

S100A16 has 4,411 functional associations with biological entities spanning 8 categories (molecular profile, organism, functional term, phrase or reference, chemical, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 86 datasets.

Click the + buttons to view associations for S100A16 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles tissues with high or low expression of S100A16 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles tissues with high or low expression of S100A16 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray tissue samples with high or low expression of S100A16 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq tissue samples with high or low expression of S100A16 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset.
Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles tissues with high or low expression of S100A16 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset.
BioGPS Human Cell Type and Tissue Gene Expression Profiles cell types and tissues with high or low expression of S100A16 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset.
BioGPS Mouse Cell Type and Tissue Gene Expression Profiles cell types and tissues with high or low expression of S100A16 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset.
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of S100A16 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
CCLE Cell Line Gene Expression Profiles cell lines with high or low expression of S100A16 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset.
CCLE Cell Line Proteomics Cell lines associated with S100A16 protein from the CCLE Cell Line Proteomics dataset.
CellMarker Gene-Cell Type Associations cell types associated with S100A16 gene from the CellMarker Gene-Cell Type Associations dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of S100A16 gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of S100A16 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
ChEA Transcription Factor Targets 2022 transcription factors binding the promoter of S100A16 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset.
CM4AI KOLF21J CRISPRi Gene Perturbation Atlas gene perturbations changing expression of S100A16 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores cellular components containing S100A16 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset.
COMPARTMENTS Experimental Protein Localization Evidence Scores cellular components containing S100A16 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of S100A16 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
COSMIC Cell Line Gene Mutation Profiles cell lines with S100A16 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset.
CTD Gene-Chemical Interactions chemicals interacting with S100A16 gene/protein from the curated CTD Gene-Chemical Interactions dataset.
CTD Gene-Disease Associations diseases associated with S100A16 gene/protein from the curated CTD Gene-Disease Associations dataset.
DeepCoverMOA Drug Mechanisms of Action small molecule perturbations with high or low expression of S100A16 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset.
DepMap CRISPR Gene Dependency cell lines with fitness changed by S100A16 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 diseases co-occuring with S100A16 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
DisGeNET Gene-Disease Associations diseases associated with S100A16 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.
DisGeNET Gene-Phenotype Associations phenotypes associated with S100A16 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at S100A16 gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of S100A16 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of S100A16 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
ESCAPE Omics Signatures of Genes and Proteins for Stem Cells PubMedIDs of publications reporting gene signatures containing S100A16 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset.
GeneRIF Biological Term Annotations biological terms co-occuring with S100A16 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
GeneSigDB Published Gene Signatures PubMedIDs of publications reporting gene signatures containing S100A16 from the GeneSigDB Published Gene Signatures dataset.
GEO Signatures of Differentially Expressed Genes for Diseases disease perturbations changing expression of S100A16 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of S100A16 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Kinase Perturbations kinase perturbations changing expression of S100A16 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of S100A16 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset.
GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations transcription factor perturbations changing expression of S100A16 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Viral Infections virus perturbations changing expression of S100A16 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset.
GO Biological Process Annotations 2015 biological processes involving S100A16 gene from the curated GO Biological Process Annotations 2015 dataset.
GO Cellular Component Annotations 2015 cellular components containing S100A16 protein from the curated GO Cellular Component Annotations 2015 dataset.
GO Cellular Component Annotations 2023 cellular components containing S100A16 protein from the curated GO Cellular Component Annotations 2023 dataset.
GO Molecular Function Annotations 2015 molecular functions performed by S100A16 gene from the curated GO Molecular Function Annotations 2015 dataset.
GO Molecular Function Annotations 2023 molecular functions performed by S100A16 gene from the curated GO Molecular Function Annotations 2023 dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of S100A16 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of S100A16 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
GTEx Tissue Sample Gene Expression Profiles tissue samples with high or low expression of S100A16 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset.
Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles cell lines with high or low expression of S100A16 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset.
HPA Cell Line Gene Expression Profiles cell lines with high or low expression of S100A16 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset.
HPA Tissue Gene Expression Profiles tissues with high or low expression of S100A16 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset.
HPA Tissue Protein Expression Profiles tissues with high or low expression of S100A16 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset.
HPA Tissue Sample Gene Expression Profiles tissue samples with high or low expression of S100A16 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset.
HPM Cell Type and Tissue Protein Expression Profiles cell types and tissues with high or low expression of S100A16 protein relative to other cell types and tissues from the HPM Cell Type and Tissue Protein Expression Profiles dataset.
Hub Proteins Protein-Protein Interactions interacting hub proteins for S100A16 from the curated Hub Proteins Protein-Protein Interactions dataset.
HuBMAP Azimuth Cell Type Annotations cell types associated with S100A16 gene from the HuBMAP Azimuth Cell Type Annotations dataset.
IMPC Knockout Mouse Phenotypes phenotypes of mice caused by S100A16 gene knockout from the IMPC Knockout Mouse Phenotypes dataset.
InterPro Predicted Protein Domain Annotations protein domains predicted for S100A16 protein from the InterPro Predicted Protein Domain Annotations dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of S100A16 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of S100A16 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles cell lines with high or low expression of S100A16 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset.
KnockTF Gene Expression Profiles with Transcription Factor Perturbations transcription factor perturbations changing expression of S100A16 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset.
LOCATE Curated Protein Localization Annotations cellular components containing S100A16 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset.
LOCATE Predicted Protein Localization Annotations cellular components predicted to contain S100A16 protein from the LOCATE Predicted Protein Localization Annotations dataset.
MGI Mouse Phenotype Associations 2023 phenotypes of transgenic mice caused by S100A16 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset.
MiRTarBase microRNA Targets microRNAs targeting S100A16 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of S100A16 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
MoTrPAC Rat Endurance Exercise Training tissue samples with high or low expression of S100A16 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset.
MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations gene perturbations changing expression of S100A16 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset.
NURSA Protein Complexes protein complexs containing S100A16 protein recovered by IP-MS from the NURSA Protein Complexes dataset.
Pathway Commons Protein-Protein Interactions interacting proteins for S100A16 from the Pathway Commons Protein-Protein Interactions dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of S100A16 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations gene perturbations changing expression of S100A16 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
PFOCR Pathway Figure Associations 2023 pathways involving S100A16 protein from the PFOCR Pathway Figure Associations 2023 dataset.
PFOCR Pathway Figure Associations 2024 pathways involving S100A16 protein from the Wikipathways PFOCR 2024 dataset.
Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles cell types and tissues with high or low DNA methylation of S100A16 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset.
Roadmap Epigenomics Cell and Tissue Gene Expression Profiles cell types and tissues with high or low expression of S100A16 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at S100A16 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.
Rummagene Transcription Factor Associations 2026 transcription factors regulating expression of S100A16 gene from the Rummagene Transcription Factor Associations 2026 dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of S100A16 gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of S100A16 gene from the RummaGEO Gene Perturbation Signatures dataset.
Sanger Dependency Map Cancer Cell Line Proteomics cell lines associated with S100A16 protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset.
TargetScan Predicted Conserved microRNA Targets microRNAs regulating expression of S100A16 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset.
TargetScan Predicted Nonconserved microRNA Targets microRNAs regulating expression of S100A16 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset.
TCGA Signatures of Differentially Expressed Genes for Tumors tissue samples with high or low expression of S100A16 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores tissues with high expression of S100A16 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores tissues with high expression of S100A16 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores tissues co-occuring with S100A16 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset.